News

Clinical trial results showed that full-body magnetic resonance imaging (MRI) scans do not affect the Medtronic Evera MRI SureScan implantable cardioverter defibrillator’s (ICD) ability to detect...

Greatbatch Medical, Myopore Sutureless Myocardial Pacing Lead

A new epicardial pacing lead has been cleared by the U.S. Food and Drug Adminitysration (FDA) as an option for the implant of a pacemaker, defibrillator, or cardiac resynchronization therapy (CRT...

HRS, remote monitoring, RM, standard of care, CIEDs

A new expert consensus statement by the Heart Rhythm Society (HRS) recommends remote monitoring (RM) become standard of care for patients with cardiovascular implantable electronic devices (CIEDs...

Geneva Healthcare, Geneva Healthcare Suite 2.0, HRS, patient engagement

Geneva Healthcare will showcase a set of new features on The Geneva Healthcare Suite – a technology platform for managing data from cardiac devices – at Heart Rhythm Society's annual scientific...

St. Jude Medical, ICD, MRI-conditional, CE mark, Europe, pacemakers

St. Jude Medical Inc. announced CE Mark approval of expanded labeling for its Ellipse implantable cardioverter defibrillator (ICD), in addition to its Durata and Optisure defibrillation leads. The...

Accreditation for Cardiovascular Excellence, standards, EP, ICDs, guidelines

Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and implantable cardioverter defibrillator (ICD) standards for accreditation. Driven by...

May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place...

Boston Scientific, investors, cardiology, growth, expansion

Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth strategies at a meeting with the investment community May 1.

ScottCare, Ambucor, HRS, 2015, ECG, remote monitoring

The ScottCare Corp. announced it will highlight Ambucor, the company’s employable labor service division for CIED monitoring, at the 2015 Heart Rhythm Society Scientific Sessions in Boston, May 13...

Biotronik, DX, ICD, Inventra, Itrevia, FDA, ultra-high energy

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (ICDs) that can deliver ultra-high energy on the first...

Boston Scientific, S-ICD, long-term data, TV-ICD, trial

The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific Corp. S-ICD System (subcutaneous implantable...

Emblem S-ICD, implantable cardioverter defibrillator, Boston Scientific, FDA, CE

Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) and CE Mark approval of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) system. The Emblem S-ICD system is a...

Biotronik, ProMRI, AFFIRM, trial, ICD, MRI systems, EP Lab

Biotronik announced that its ProMRI and ProMRI AFFIRM studies have been published in Heart Rhythm, the official journal of the Heart Rhythm Society, validating the...

Quadripolar lead, Medtronic, Attain, VivaQuad, CRT-D

There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient monitoring to avoid needless shocks, the...

EP lab, Implantable Cardioverter Defibrillators, Heart Failure

Boston Scientific Corporation announced the launch and first U.S. implant of its line of Extended Longevity (EL) implantable cardioverter defibrillators (ICD), including Dynagen EL and Inogen EL...

Cardiac Resynchonization Therapy (CRT), Implantable cardioverster defibrillators

Medtronic announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm.

Biotronik announced the publication of new findings from the REPLACE Registry in Circulation: Arrhythmia and Electrophysiology. The Biotronik-sponsored REPLACE Registry...

Medtronic, Attain Performa, quadripolar leads

Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV) quadripolar leads. Both devices can be...

implantable cardioverter defibrillator, ep lab, leads, implantable devices

A new study evaluating Optim-insulated implantable cardioverter defibrillator (ICD) leads found low rates of all-cause mechanical failure during a median follow-up of 3.2 years.

Most patients with implantable cardioverter defibrillators (ICDs) haven’t thought about device deactivation if they were to develop a serious illness from which they were not expected to recover...